Genesys International Approves Rights Issue of ₹1253 Crore
Genesys International approved a Rights Issue of 2,50,74,226 equity shares at ₹50 each, totaling ₹1253.71 crore. The record date is August 06, 2026. The issue opens on August 14, 2026, and closes on August 21, 2026. Shareholders will receive 3 rights shares for every 5 held.
A rights issue of this magnitude can significantly impact the company's capital structure, share count, and future financial performance.
The approval of a rights issue to raise capital is generally viewed positively as it can fund growth or strengthen the balance sheet.
Genesys International Corporation Limited's Rights Issue Committee, in a meeting held on July 31, 2026, approved the terms for a Rights Issue of equity shares. This follows a Board of Directors' meeting on June 26, 2026, which initially approved the issue.
The Rights Issue will offer 2,50,74,226 fully paid-up equity shares of face value ₹5 each, at a price of ₹50 per share (including a premium of ₹45). The total issue size is not exceeding ₹12,537.11 lakhs (₹1253.71 crore).
The record date for determining eligible shareholders is Thursday, August 06, 2026. Eligible shareholders will receive 3 rights equity shares for every 5 fully paid-up equity shares held.
The Rights Issue will open on Friday, August 14, 2026, with the on-market renunciation period also starting on the same date and ending on Tuesday, August 18, 2026. The Rights Issue is scheduled to close on Friday, August 21, 2026, with the possibility of extension.
Post the Rights Issue, assuming full subscription, the company's outstanding equity shares will increase from 4,17,90,377 to 6,68,64,603.
What to do with a filing like this
Genesys International Corporation Limited filed this with the NSE as a statutory disclosure, categorised under rights issue. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Genesys International Corporation Limited. Read the original for the full detail.